Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1245 Wilshire Blvd
Ste 380
Los Angeles, CA 90017Phone+1 213-483-8810Fax+1 213-481-1503
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1987 - 1990
- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1986 - 1987
- Icahn School of Medicine at Mount SinaiClass of 1986
Certifications & Licensure
- CA State Medical License 1990 - 2025
- NV State Medical License 1994 - 2005
- UT State Medical License 1996 - 2000
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification SRS EHR, SRSsoft, 2013
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
- Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 125 citationsProgression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.Tiarnan D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten
Ophthalmology. 2018-12-01 - 35 citationsNatural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
Ophthalmology. 2019-02-01 - 42 citationsRandomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.John F. Payne, Charles C. Wykoff, W. Lloyd Clark, Beau B. Bruce, David S. Boyer
American Journal of Ophthalmology. 2019-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: